Brief: Neoleukin Therapeutics Announces Third Quarter 2022 Financial Results

Neurogene

14/11/2022 21:47

Nov 14 (Reuters) - Neoleukin Therapeutics Inc  NLTX.O :
    * NEOLEUKIN THERAPEUTICS ANNOUNCES THIRD QUARTER 2022
FINANCIAL
RESULTS AND CORPORATE UPDATE
    * NEOLEUKIN THERAPEUTICS INC - COMPANY RESTRUCTURING TO
EXTEND
CASH RUNWAY INTO SECOND HALF OF 2025
    * NEOLEUKIN - CASH, CASH EQUIVALENTS, AND SHORT-TERM
INVESTMENTS
TOTALED $106.9 MILLION AS OF SEPT 30, 2022, COMPARED TO $142.5
MILLION AS OF DEC 31, 2021

Source text for Eikon:  ID:nGNX47hFwG 
Further company coverage:  NLTX.O 
 ((Reuters.Briefs@thomsonreuters.com;))